Allergan Inc $164.38

up +1.25


21/8/2014 04:00 PM  |  NYSE : AGN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get AGN Trend Analysis - it has outperformed the S&P 500 by 57%

Partner Headlines

  1. S&P 500 Marks New High As Indexes Hold Gains

    IBD
  2. SALIX PHARMACEUTICALS

    IBD
  3. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD
  4. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga
  5. Salix Soars On Allergan Buzz

    IBD
  6. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  7. Dow Flirts With 19,000, S&P 500 Approaches 2,000 & Nasdaq Trading At 14-Year ...

    Benzinga
  8. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD
  9. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD
  10. Allergan On The Acquisition Hunt

    Benzinga
  11. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And ...

    Benzinga
  12. Allergan

    IBD
  13. Allergan Takes In 13 New Hedge Fund Investments In Q2

    Benzinga
  14. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  15. Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension ...

    Benzinga
  16. Benzinga's M&A Chatter for Monday August 11, 2014

    Benzinga
  17. Valeant Pharmaceuticals'

    IBD
  18. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  19. Allergan

    IBD
  20. Allergan Rebounds After Analyst Upgrades On Valuation

    IBD
  21. Benzinga's Top Upgrades

    Benzinga
  22. Leerink Swann Upgrades Allergan To Outperform

    Benzinga
  23. Fast Money Picks For August 8

    Benzinga
  24. Top Performing Funds Play Favorits

    IBD
  25. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  26. Thursday's Selling Momentum Continues In To Friday

    Benzinga
  27. Thursday's Selling Momentum Continues Into Friday

    Benzinga
  28. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  29. Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan ...

    Benzinga
  30. Valeant Guides Outlook Low

    IBD
  31. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  32. Valeant Q2 Meets Views; Guidance Down On Asset Sale

    IBD
  33. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  34. George Soros Reveals His Largest Stake

    GuruFocus
  35. Earnings Season Boosts Confidence; S&P Trades At Record Highs

    Benzinga
  36. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  37. UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways

    Benzinga
  38. Allergan EPS Gains Accelerate

    IBD
  39. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  40. UPDATE: Allergan Posts Upbeat Q2 Earnings, Plans To lower 13% Of Workforce

    Benzinga
  41. Allergan to Slash 13% of its Global Workforce

    FoxBusiness
  42. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  43. Earnings Scheduled For July 21, 2014

    Benzinga
  44. Stocks To Watch For July 21, 2014

    Benzinga
  45. Pershing Square Releases Letter To Allergan's Board Of Directors, Fund ...

    Benzinga
  46. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
  47. Allergan Issues Comment on Pershing's Definitive Proxy Statement

    Benzinga
  48. Apple And 4 Other Environmentally Responsible Companies

    Benzinga
  49. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  50. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga
Trading Center